Hi-Clearance

1788 · TWO · Healthcare / Medical Devices

125.50TWD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close125.50

Open125.50

Day Range125.00 – 125.50

52-Week Range126.15 – 134.50

Volume6.38K

Market Cap5.70B

P/E (TTM)14.55

Forward P/E13.24

EPS8.80

Dividend Yield5.49%

Beta0.10

50-Day Avg129.13

200-Day Avg133.56

About

Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dentistry, oral surgery, thoracic, respiratory, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and, RO machines, and related consumables and drugs; interventional cardiology and radiology, and plastic surgery devices; dentistry consumables, implant materials, and equipment; and blood glucose monitors, and related consumables and nutrition products, as well as hemodialysis management services. It engages in the design and management of dialysis centers; and sale and service of healthy and natural drinks, as well as operates as an OEM supplier for beverage raw materials and concentrates. Hi-Clearance Inc. was founded in 1989 and is headquartered in New Taipei City, Taiwan.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOMr. Kuo-Shih Chen
Employees0
HeadquartersNo. 2, Chongxin Road, New Taipei City, Taiwan, 24159, Taiwan
Websitehttps://www.hiclearance.com.tw

Leadership

Mr. Kuo-Shih ChenManager
Yaw-Yuan ChangChief Accountant

Financials

Income Statement

Currency: TWD	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	2.74B	2.83B	2.96B	3.10B	3.24B	3.43B	3.68B	4.69B	3.90B	4.07B	4.28B
Growth (%)	-	+3.38%	+4.46%	+4.61%	+4.70%	+5.90%	+7.34%	+27.30%	-16.93%	+4.54%	+5.04%
Cost of Revenue	2.16B	2.24B	2.29B	2.41B	2.50B	2.58B	2.72B	3.64B	2.88B	3.00B	3.13B
Gross Profit	583.26M	597.47M	668.58M	684.00M	735.77M	849.35M	968.97M	1.05B	1.02B	1.07B	1.14B
Gross Margin	21.29%	21.09%	22.60%	22.10%	22.70%	24.75%	26.30%	22.29%	26.07%	26.28%	26.73%
Operating Expense	350.63M	354.99M	396.62M	387.04M	408.20M	449.40M	521.77M	575.24M	600.55M	642.57M	721.87M
Operating Income	232.63M	242.48M	271.96M	296.96M	327.57M	399.95M	447.20M	470.10M	415.24M	427.87M	421.57M
Operating Margin	8.49%	8.56%	9.19%	9.59%	10.11%	11.65%	12.14%	10.02%	10.66%	10.51%	9.85%
EBITDA	-	-	337.73M	348.67M	433.54M	531.46M	597.97M	631.13M	611.50M	647.83M	672.84M
EBITDA Margin	-	-	11.41%	11.27%	13.38%	15.49%	16.23%	13.46%	15.70%	15.91%	15.73%
Net Income	216.89M	207.56M	251.08M	243.45M	245.74M	317.29M	348.59M	366.43M	347.98M	359.69M	368.51M
Net Income Margin	7.92%	7.33%	8.49%	7.87%	7.58%	9.25%	9.46%	7.81%	8.93%	8.83%	8.61%
Interest Expense	0	0	0	2.23M	15.71M	17.35M	14.50M	12.77M	12.44M	13.81M	17.64M
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	0.07%	0.48%	0.51%	0.39%	0.27%	0.32%	0.34%	0.41%

Balance Sheet

Currency: TWD	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	2.43B	2.47B	2.61B	2.97B	3.73B	4.20B	4.44B	4.51B	4.62B	4.96B	5.08B
Total Liabilities	905.20M	912.94M	988.28M	1.33B	1.94B	2.19B	2.13B	2.07B	1.63B	1.96B	2.03B
Total Equity	1.53B	1.56B	1.63B	1.64B	1.78B	2.01B	2.30B	2.44B	2.98B	3.00B	3.05B
Cash	185.18M	294.94M	281.99M	285.89M	479.40M	412.78M	345.01M	324.22M	401.14M	414.87M	463.96M
Total Debt	-	-	-	-	1.08B	1.26B	1.14B	1.04B	-	-	-
Net Debt	-	-	-	131.28M	596.33M	845.19M	797.62M	717.88M	-	-	60.08M

Cash Flow

Currency: TWD	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	49.45M	328.02M	242.70M	314.23M	256.67M	413.16M	287.79M	403.16M	433.49M	510.12M	389.54M
Investing Cash Flow	59.23M	-4.32M	-114.95M	-291.20M	-37.55M	-385.53M	-158.04M	-	-	-	-
Financing Cash Flow	-152.62M	-211.87M	-135.10M	-21.23M	-23.93M	-93.51M	-196.90M	-342.13M	-	-	-
Capital Expenditure	10.85M	8.99M	110.89M	268.63M	38.26M	232.16M	150.51M	102.67M	64.33M	284.57M	111.12M
Free Cash Flow	-	-	131.81M	45.60M	218.41M	181.01M	137.28M	300.49M	369.16M	225.55M	278.43M
Dividends Paid	175.00M	175.00M	175.00M	210.00M	216.00M	216.00M	263.27M	283.65M	311.65M	311.65M	311.65M
FCF to OCF	-	-	54.31%	14.51%	85.10%	43.81%	47.70%	74.53%	85.16%	44.21%	71.48%
Dividend Paid to FCF	-	-	132.77%	460.53%	98.90%	119.33%	191.77%	94.39%	84.42%	138.17%	111.93%

Earnings

Report Date	May 14, 2014	Aug 11, 2014	Nov 11, 2014	Nov 11, 2015
EPS Estimate	2.01	1.36	2.04	1.36
EPS Actual	1.39	1.57	1.68	1.39
Surprise	-30.85%	15.44%	-17.65%	2.21%
Timing	Pre-market	Pre-market	After-hours	After-hours

Key Statistics & Ratios

Market Cap5.70B

Enterprise Value6.27B

Trailing P/E14.55

Forward P/E13.24

Price / Sales1.29

Price / Book1.92

EPS8.80

Book Value66.31

Revenue (TTM)4.41B

Gross Profit (TTM)1.24B

EBITDA583.71M

Profit Margin8.89%

Operating Margin10.75%

Return on Equity13.48%

Return on Assets5.63%

Shares Outstanding44.52M

Shares Float25.29M

Beta0.10

Dividend Yield5.49%

Dividend Rate7.00

Payout Ratio79.55%

Dividends

20261×

7.00Jun 16, 2026

20251×

7.00Jun 23, 2025

20241×

7.00Jun 14, 2024

20231×

7.00Jul 3, 2023

20221×

6.93Jul 19, 2022

20211×

6.70Aug 2, 2021

20201×

5.94Jul 13, 2020

20191×

5.94Jul 29, 2019

20181×

5.91Jul 9, 2018

20171×

4.93Jun 22, 2017

20161×

4.93Jun 30, 2016

20151×

4.93Jun 18, 2015

20141×

4.93Jul 11, 2014

20131×

3.94Jul 25, 2013

20121×

3.45Jul 9, 2012

20111×

3.37Jul 5, 2011

20101×

3.08Jul 29, 2010

20091×

2.89Jun 25, 2009

20081×

3.66Jul 15, 2008